The biggest challenge facing clinical research today is the need to gather, analyze, and report data – quickly and remotely. To collect patient data more efficiently, the industry has turned to electronic patient-reported outcome (ePRO) tools. Early on, patients were provided with devices to use. But as more than three-quarters of Americans own smartphones, researchers are increasingly exploring bring your own device (BYOD) strategies in which patients utilize their own devices to collect clinical trial data. 

With BYOD, not only are your sites and patients assured peace of mind and an easier experience, but you can be confident that your patients are more adherent, more engaged, and that your protocol is being executed correctly.

While an increasing number of trials have successfully deployed this model with great results, some CROs and sponsors are still hesitant because of the absence of FDA guidance on the matter. Clinical Ink is the BYOD leader; we have BYOD experience with 15,000 patients in Phase I-IV+ trials. In this white paper, we aim to answer all your BYOD questions and address all your BYOD concerns.